Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser offers new hope for glaucoma patients

NCT ID NCT05654493

Summary

This study followed 65 glaucoma patients for one year after they received a specific laser treatment called MP-TSCPC. Researchers wanted to see how well this laser procedure lowered eye pressure and reduced the need for daily eye-drop medications. They tracked patients' vision, eye health, and any side effects over time to understand the treatment's real-world effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mayo Clinic Florida

    Jacksonville, Florida, 32224, United States

Conditions

Explore the condition pages connected to this study.